A recent review article investigated the importance of hyaluronic acid chain lengths in eye drops for the physical as well as physiological performance of the drops. The classification according to average molecular weight was proposed: LMW HA (low molecular weight hyaluronic acid: < 1.5 MDa), MMW HA (medium molecular weight hyaluronic acid: 1.5 – 2.3 … Continue reading Hylan A supports the growth of corneal nerves in patients suffering from severe dry eye disease
Tag: hyaluronic acid
Tearfilm oriented dry eye therapy
In 2017 the Tear Film and Ocular Surface Society (TFOS) published the results of the second Dry Eye Workshop (DEWS II) in a number of consensus papers on the definition, diagnosis, pathophysiology and treatment of dry eyes. DEWS II defined dry eye as “a multifactorial disease of the ocular surface characterized by a loss of homeostasis … Continue reading Tearfilm oriented dry eye therapy
Hyaluronan supports wound healing in diabetes
The application of high molecular weight hyaluronan (hyaluronic acid) eye drops is likely to be indicated before and after any ocular surgery in diabetic patients. In 2011 Galeano et al. reported that the skin of diabetic mice contains one third less hyaluronan than that of non-diabetic mice of the same race (https://www.sciencedirect.com/science/article/pii/S0925443911000676?via%3Dihub). It was known … Continue reading Hyaluronan supports wound healing in diabetes
Dr. Mueller-Lierheim 